Increasing consumer healthcare spending on dietary supplements and medicines to maintain a healthy lifestyle will promote the oryzanol market growth. The ingredient is highly beneficial due to its high cholesterol controlling properties. Large product availability along with safety approvals from the FDA has promulgated the product demand in various industries including cosmetics, nutraceuticals, and pharmaceuticals.

Shifting trends towards fitness has created the demand for sport supplements to help in body building among young population. Oryzanol based sport supplements are considered to be highly safe due to its natural extraction from the rice bran oil. No legal limitation over its consumption makes it more popular among athletes.

The ingredient is used in anti-aging, skin whitening, and sunblock creams in the cosmetic industry. Rich in antioxidants and scavenging toxicity from the skin has made the product popular in skin care applications. Cosmetic sector is expected to observe more than 12% growth up to 2025 in oryzanol market.

Pharmaceuticals dominated the overall industry demand and accounts for more than half of the volume share in 2018. Rising heart related diseases due to high occurrence of LDL among population of all age groups has surged the consumption of cholesterol control medicines. As cholesterol doesn’t have any specific symptoms which induce the consumer to keep a check on health and take precautionary medicines.

North America oryzanol market is projected to witness over 14% CAGR from 2018 to 2025. High consumer spending along with increasing health awareness programs by the government to control premature deaths from heartache will drive the regional industry growth. It is estimated that in the U.S. over 50% of the adult population take prescribed cholesterol control remedies. The region also has a dominating share in the overall sport nutrition spending and held responsible for more than 40% of the consumption.

Asia Pacific accounted for more than 30% of the overall oryzanol demand in 2018. Raw material accessibility at a large scale coupled with the presence of major manufacturers are among the key factors influencing industry growth. China, India, and Japan are the major contributing countries in the region and together accounted for more than 65% of the demand in 2018.

Nutraceuticals and sport supplement applications will witness the highest growth in the European oryzanol market. Germany, France, and the UK are the key promising countries in the region due to their significant growth rate in the industry. The overall demand for pharmaceuticals can be impacted by the increasing consumption of rice bran oil in cooking applications which eliminates the requirement of oryzanol based cholesterol controlling medicines.

The global oryzanol industry share is highly consolidated in nature and the majority of the companies are located in Asian countries. China and Japan are the two major companies with highest innovations in the oryzanol industry, with India being the largest producer of rice bran. TSUNO, Okayasu, Oryza Oil & Fat Chemical, Henry Lamotte Oils, Kangcare, Delekang Food, and Jining Ankang Pharmaceuticals are the key identified players in the market. Production capacity to target the addressable market due to high share of the underutilized extraction process.